Digital health tools in the reproductive space often blur the line between wellness and medical care, which can obscure their ...

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet issue for Commissioner Marty Makary that’s separately garnered attention in ...

The Controversial Sale of 23andMe's Genetic Data** A significant ruling is imminent regarding the sale of 23andMe’s vast repository of genetic data—a move that has raised alarm bells across many ...

UnitedHealth Group confirms federal criminal and civil investigations by DOJ in SEC filing as healthcare giant faces mounting legal scrutiny.

A federal judge on Thursday declined to block the bankruptcy sale of genetic testing company 23andMe to its co-founder Anne Wojcicki pending the outcome of a legal challenge by California.

President Trump is scheduled to visit the Federal Reserve’s headquarters Thursday, joining other administration officials who have requested a site tour because of scrutiny of renovations of the ...

(The Hill) – President Trump is scheduled to visit the Federal Reserve’s headquarters on Thursday, joining other administration officials who have requested a site tour because of scrutiny of ...

(The Hill) – President Trump is scheduled to visit the Federal Reserve’s headquarters on Thursday, joining other administration officials who have requested a site tour because of scrutiny of ...

UnitedHealth is cooperating with the DOJ on Medicare-related inquiries and has launched third-party reviews to ensure transparency and compliance.

Columbia University said Wednesday it has agreed to pay the Trump administration $221 million to restore federal funding that was stripped following a probe into antisemitism on the campus.

Kaiser Permanente will pause gender-affirming surgeries for patients under 19 starting August 29, 2025, in response to growing federal scrutiny. Non-surgical care will continue.